In this interview, we spoke to Dr Percy Luu, Founder and CEO of Incando Therapeutics to find out about his experience starting and growing a very early-stage therapeutics start-up company in Singapore.
COVID-19 has greatly affected the construction industry by causing employee absenteeism, a problem which leads to project delays and loss of revenue for many companies. Hear about how Genscript’s new SARS-CoV-2 cPass™ serology test for neutralising antibodies has been helping construction workers make informed decisions to take vaccine boosters and stay protected.
In this interview, we spoke to Mr Kuan Chee Mun, Executive Director, and Dr. Andrea Pavesi, Consultant, to find out about AIM Biotech’s journey as a start-up, their experiences navigating the biotech industry as start-up founders, and to seek their advice for aspiring start-ups in Singapore.
In this new and exciting article we capture the journey of two public-listed company – iX Biopharma and ASLAN Pharmaceuticals, listed on SGX and Nasdaq respectively in a series of questions and answers. Hear what Ms Eva Tan, Director of Corporate and Commercial Strategy at iX Biopharma and Dr. Carl Firth, founder and CEO of ASLAN Pharmaceuticals have to say about their journey going public, and how start-ups can undertake this path successfully. By Shainan Hora
The trials and tribulations that independent biotech start-ups overcome before they soar.
Contributed by: Daphne Ng
The journey of a family-owned local biotech company.
Contributed by: by Daphne Ng